For A Better Patient Experience

Bio-Signal Sensing, Hydrogel-Free Technology for Electrodes and Wearable Devices
Request Information Flexcon® Omni-Wave™
Kontent.Ai.Delivery.ContentItems.Asset

New Possibilities in Wearables, Diagnostics, and Wellness.

No hydrogel-associated skin reactions

  • A revolutionary dry biomedical electrode technology developed with patient comfort in mind 
  • Utilizes a skin-friendly, medical grade conductive adhesive that requires no hydrogel or Ag/AgCl to get a signal, offering a hydrogel-free patient experience.

Approved component in customer 510(k) and CE marked finished good medical devices

  • Passes AAMI and ISO 10993-10 for sensitization and irritation 
  • Approved by the FDA for use in electrodes and wearables
  • REACH and RoHS compliant

Reduced waste and lower cost

  • No need to throw away unused electrodes - 3-year out-of-pack shelf life
  • No expensive barrier packaging required

Fully commercialized and ready to ship

  • Sold in roll form to be converted into finished electrodes 
  • Ready to be licensed to OEMs for incorporation into their finished devices  
  • Samples and specialist consultation available for device manufacturers and converters

Improved Performance Over Hydrogel-Based Diagnostic and Therapeutic Applications

Independent clinical studies show performance equivalent to hydrogel-based electrodes 

Humidity will not impact function.

Components are suitable for both diagnostic and therapeutic devices. They can be incorporated into sEMG devices and can distinguish between sympathetic and parasympathetic responses for EDA applications.

Improved Performance Over Hydrogel-Based Diagnostic and Therapeutic Applications

Flexcon® Omni-Wave™ Awards

  • WINNER! 2023 Med-Tech Innovation Award
  • WINNER! Worcester Business Journal 2023 Manufacturing Excellence Awards for Innovation & Top Product Design
  • FINALIST! 2023 Best in Sensors for Wearables
  • FINALIST! 2023 Best in Sensors for Medical Technology
Flexcon® Omni-Wave™ Awards
contact